Intrinsic Value Partners, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Intrinsic Value Partners, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$484,919
-9.6%
50,355
-0.1%
0.62%
-7.8%
Q2 2023$536,309
-1.2%
50,405
-2.3%
0.68%
-7.9%
Q1 2023$542,885
+84330.0%
51,605
-0.6%
0.73%
-16.6%
Q4 2022$643
-99.9%
51,905
-3.5%
0.88%
+13.7%
Q3 2022$557,000
-10.7%
53,805
-0.6%
0.77%
-2.8%
Q2 2022$624,000
-8.9%
54,105
-0.7%
0.80%
+9.6%
Q1 2022$685,000
+6.7%
54,479
-1.0%
0.73%
+6.1%
Q4 2021$642,00055,0570.68%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders